Silk Road Medical Announces up to $57 Million in New Funding for Novel Approach to Preventing Strokes

Financing to Support Commercialization of First-in-Class Products for TransCarotid Artery Revascularization (TCAR) Procedure SUNNYVALE, Calif., Oct. 20, 2015 -- (Healthcare Sales & Marketing Network) -- Silk Road Medical, Inc., a company dedicated to a... Devices, Interventional, Venture CapitalSilk Road Medical, Transcarotid Neuroprotection, Transcarotid Stent, stroke
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news